Suppr超能文献

来自晚期动脉粥样硬化病变的T细胞可识别人类热休克蛋白60(hHSP60),且其T细胞受体库有限。

T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire.

作者信息

Rossmann Andrea, Henderson Blair, Heidecker Bettina, Seiler Ruediger, Fraedrich Gustav, Singh Mahavir, Parson Walther, Keller Michael, Grubeck-Loebenstein Beatrix, Wick Georg

机构信息

Division of Experimental Pathophysiology and Immunology, Biocenter, Innsbruck Medical University, Fritz-Pregl-Strasse 3/4, Innsbruck, Austria.

出版信息

Exp Gerontol. 2008 Mar;43(3):229-37. doi: 10.1016/j.exger.2007.11.009. Epub 2007 Dec 8.

Abstract

Atherosclerosis is a multifactorial, chronic-inflammatory disease for which the underlying cause remains unknown. It is also well documented that T-cells are among the first cells to migrate into the arterial intimal vessel layer, but their function there is still unexplained. Clinical and experimental data have provided evidence that atherosclerosis starts as an autoimmune reaction based on humoral and cellular immunity against a phylogenetically highly conserved stress protein, heat shock protein 60 (HSP60). In the present study, we phenotypically characterized T-cells from endarterectomized specimens of the carotid artery, and tested their reactivity to human HSP60. In addition, the T-cell receptor repertoire of the T-cell lines was defined by immunoscope analysis. We found a mixed population of CD4(+) and CD8(+) intralesional T-cells, with a slight predominance of CD8(+) cells. IFN-gamma production prevailed over IL-4 production. The T-cell reaction against human HSP60 was significantly increased in intralesional cells compared to peripheral T-cells. The lesion-derived T-cells showed an oligoclonally-restricted repertoire, in contrast to the polyclonal pattern of PBMC. These results clearly show that HSP60 is a major antigenic candidate, and that an oligoclonal T-cell expansion takes place in advanced human atherosclerotic lesions.

摘要

动脉粥样硬化是一种多因素的慢性炎症性疾病,其根本病因尚不清楚。同样有充分文献记载的是,T细胞是最早迁移到动脉内膜血管层的细胞之一,但其在那里的功能仍无法解释。临床和实验数据已提供证据表明,动脉粥样硬化始于基于针对系统发育上高度保守的应激蛋白热休克蛋白60(HSP60)的体液免疫和细胞免疫的自身免疫反应。在本研究中,我们对来自颈动脉内膜切除术标本的T细胞进行了表型特征分析,并测试了它们对人HSP60的反应性。此外,通过免疫显微镜分析确定了T细胞系的T细胞受体库。我们发现病变内CD4(+)和CD8(+) T细胞混合存在,其中CD8(+)细胞略占优势。γ干扰素的产生超过白细胞介素-4的产生。与外周T细胞相比,病变内细胞对人HSP60的T细胞反应显著增强。与外周血单个核细胞(PBMC)的多克隆模式不同,病变来源的T细胞显示出寡克隆受限的受体库。这些结果清楚地表明,HSP60是主要的抗原候选物,并且在晚期人类动脉粥样硬化病变中发生了寡克隆T细胞扩增。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验